Impact of Continuous Pharmacist Intervention for Injectable Antimicrobials on the Treatment of Patients with Escherichia coli Bacteremia
Description
Escherichia coli (E. coli) is one of the most commonly detected organisms in patients with bacteremia, with an incidence of more than 100 cases per 100,000 person-years in older adults.1 The susceptibility of E. coli to ceftriaxone is often preserved